drugset / Trial / NCT01084135
Rivastigmine Study in Adolescents With Down Syndrome
Phase 1/2
Completed
42 enrolled
Duke University
Hugo W. Moser Research Institute at Kennedy Krieger, Inc. · collabTaishoff Family Foundation · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to determine if short term use of rivastigmine can improve functional abilities (for example, language, memory, and executive function) in adolescents with Down syndrome.
Timeline
- Start
- 2009-11
- Primary completion
- 2014-02
- Completion
- 2014-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rivastigmine | Small molecule | 4.5 mg | — |